Resumen
Tumor lysis syndrome (TLS) is a potentially life-threatening condition typically associated with the initiation of cancer treatment, leading to the rapid release of intracellular contents into the bloodstream. While most seen in hematologic malignancies, TLS can occur in solid tumors under certain conditions. In this case, a TLS was discovered in an 83-year-old female patient following a hemithyroidectomy. This case underscores the potential for TLS to occur in patients with solid tumors, particularly following surgical intervention. The clinical presentation can be severe and rapidly progressive, requiring early recognition and aggressive treatment.
Citas
1. Papapanou M, Athanasopoulos AE, Georgiadi E, et al. Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature. Med Oncol. 2023;40(8):233. doi:10.1007/s12032-023-02108-4.
2. Imhoff S, Nayyer A, Patel D. In-hospital mortality and incidence trends for tumor lysis syndrome in the United States from 2016 to 2020: a National Inpatient Sample study. J Clin Oncol. 2025;43(16 Suppl):e22536. doi:10.1200/JCO.2025.43.16_suppl.e22536.
3. Durfee EM. Tumor lysis syndrome. Crit Care Nurse. 2022;42(3):19-25. doi:10.4037/ccn2022795.
4. Rajeev K, Sumit K. Tumor lysis syndrome in a post-operated case of metastatic thyroid carcinoma. J Anaesth Ther. 2019;2:103.
5. De Leo S, Trevisan M, Re Sartò GV, et al. Letter to the Editor: Tumor lysis syndrome during selpercatinib treatment in a patient with medullary thyroid cancer. Thyroid. 2023;33(9):1130-2. doi:10.1089/thy.2023.0214.
6. Touch Medical Media Limited. Tumour lysis syndrome in solid tumours associated with tyrosine kinase inhibitors: a case illustrated [Internet]. touchONCOLOGY; 2019 Mar 27 [cited 2026 Jun 7]. Available from: https://touchoncology.com/tumour-lysis-syndrome-in-solid-tumours-associated-with-tyrosine-kinase-inhibitors-a-case-illustrated-review/
7. Gbaguidi X, Goodrich L, Roca F, Suel P, Chassagne P. Bulky solid tumors in elderly adults: beware of spontaneous tumor lysis syndrome. J Am Geriatr Soc. 2016;64(1):235-7. doi:10.1111/jgs.13901.
8. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767-78. doi:10.1200/JCO.2007.15.0177.
9. Barbar T, Jaffer Sathick I. Tumor lysis syndrome. Adv Chronic Kidney Dis. 2021;28(5):438-446.e1. doi:10.1053/j.ackd.2021.09.007.
10. Sury K. Update on the prevention and treatment of tumor lysis syndrome. J Onco-Nephrol. 2019;3(1):19-30. doi:10.1177/2399369319837212.
11. Larson R, Pui CH. Tumor lysis syndrome: prevention and treatment [Internet]. In: UpToDate. Waltham (MA): UpToDate Inc.; 2024 Jul [cited 2026 Jun 7]. Available from: https://www.uptodate.com
12. Perissinotti AJ, Bishop MR, Bubalo J, et al. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: results of a modified Delphi panel. Cancer Treat Rev. 2023;120:102603. doi:10.1016/j.ctrv.2023.102603.
Copyright
License
Copyright (c) 2026 Daniela Saenz Salazar, Santiago Montenegro, Dr. Marco A. Peñalonzo, Dr. Carlos R. Cordón, Dr. Danilo Torselli-Valladares
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC_SA 4.0) that indicates: a) It is allowed that others share the work, with an acknowledgement of the work's authorship and initial publication in this journal, b) The work may not be used for commercial purposes, c) If it's remixed, transformed, or built upon the material, one must distribute the contributions under the same license as the original
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, website or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
